CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The TETRA project aims to enhance treatment for patients with severe airway diseases by developing advanced tracheal scaffolds using patients' own stem cells. The goal is to reduce the need for risky surgeries and improve patient outcomes through innovative tissue engineering.
CLINICAL PROBLEM AND UNMET NEEDThere are 11,827 patients with severe structural airway disease in Europe.
Even with the current standard of care, when hospitalised this group of patients has a 22% risk of dying.
Patients are currently subjected to repeated surgical interventions (stent insertion) which have a high failure rate.
Other therapeutic strategies under development include synthetic tracheal scaffolds seeded with patients own stem cells.
Preliminary data show that these scaffolds are…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Lincoln
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
United Kingdom, London
Type: Research institute
Activity type: Research Organisations
SME: Yes
United Kingdom, Hartley Wintney
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
